Efficacy and Safety of Pirfenidone in Patient With Dermatomyositis Interstitial Lung Disease (Dm-ILD) Efficacy and Safety of Pirfenidonein Patient With Dermatomyositis Interstitial Lung Disease (Dm-ILD) ...
A Phase III, Randomized, Double-blind, Placebo Controlled, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Pirfenidone in Subjects With Dermatomyositis Interstitial Lung Disease (Dm-ILD) A Phase III, Randomized, Double-blind, Placebo Controlled, Multicenter Clinical Trial to Evaluate th ...
Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis Pirfenidonein Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyo ...
Randomized Controlled Trial of Pirfenidone in Patients With Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis Randomized Controlled Trial of Pirfenidonein Patients With Progressive Interstitial Lung Disease Ass ...
An observation of Pirfenidone in patients with rapidly progressive interstitial lung disease secondary to clinically amyopathic dermatomyositis An observation of Pirfenidonein patients with rapidly progressive interstitial lung disease secondar ...
An observation of Pirfenidone in patients with rapidly progressive interstitial lung disease secondary to clinically amyopathic dermatomyositis An observation of Pirfenidonein patients with rapidly progressive interstitial lung disease secondar ...